Literature DB >> 2229100

Heterogeneity of vascular muscarinic receptors.

R M Eglen1, R L Whiting.   

Abstract

Muscarinic receptors mediate diverse effects on the vasculature. Recently, a consensus has been arrived at with regard to muscarinic receptor classification (Levine & Birdsall, 1989). As a result, it may now be possible to clarify the role of each subtype in the responses of vascular tissues to muscarinic agonists. It is apparent that vascular muscarinic receptors form a heterogeneous population. M1 receptors contract canine venous tissue, whilst M3 receptors contract porcine and bovine coronary arteries. M3 receptors also mediate EDRF-dependent relaxant responses in the majority of tissues studied to date. M2 receptors elicit relaxations by a decrease in sympathetic outflow in canine femoral vein, rabbit ear artery and rat portal vein. These conclusions are primarily derived from functional estimations of equilibrium dissociation constants, since comparable radioligand binding data are both scarce and contradictory. It is concluded that all three major subtypes of receptors are present in the vasculature. However, the limited selectivity of the available antagonists, the lack of extensive use of such compounds and the unavailability of selective agonists clearly indicate the need for more definitive studies to be undertaken.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229100     DOI: 10.1111/j.1474-8673.1990.tb00023.x

Source DB:  PubMed          Journal:  J Auton Pharmacol        ISSN: 0144-1795


  18 in total

1.  Vasodilatation and smooth muscle membrane potential changes in arterioles from the guinea-pig small intestine.

Authors:  N Kotecha; T O Neild
Journal:  J Physiol       Date:  1995-02-01       Impact factor: 5.182

2.  Actions of vasodilator nerves on arteriolar smooth muscle and neurotransmitter release from sympathetic nerves in the guinea-pig small intestine.

Authors:  N Kotecha; T O Neild
Journal:  J Physiol       Date:  1995-12-15       Impact factor: 5.182

Review 3.  Muscarinic receptors and drugs in cardiovascular medicine.

Authors:  P A van Zwieten; H N Doods
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

4.  Different muscarinic receptor subtypes mediating the phasic activity and basal tone of pig isolated intravesical ureter.

Authors:  M Hernández; U Símonsen; D Prieto; L Rivera; P García; E Ordaz; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

5.  Presynaptic muscarinic receptor subtypes involved in the inhibition of acetylcholine and noradrenaline release in bovine cerebral arteries.

Authors:  M Ferrer; R Galván; J Marín; G Balfagón
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

6.  Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries.

Authors:  U Simonsen; D Prieto; L Rivera; M Hernández; M J Mulvany; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  The cholinomimetic agent bethanechol activates IK(ACh) in feline atrial myocytes.

Authors:  Dora E Benavides-Haro; Ricardo A Navarro-Polanco; José A Sánchez-Chapula
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-05       Impact factor: 3.000

8.  Characterization of muscarinic receptors mediating release of epithelial derived relaxant factor (EpDRF) in guinea-pig isolated trachea.

Authors:  R M Eglen; G C Harris; M Taylor; J R Pfister; R L Whiting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

9.  Release of endothelium-derived hyperpolarizing factor (EDHF) by M3 receptor stimulation in guinea-pig coronary artery.

Authors:  A K Hammarström; H C Parkington; H A Coleman
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

10.  Effect of the effluent released from the canine internal mammary artery after intraluminal and extraluminal perfusion of acetylcholine and adenosine diphosphate.

Authors:  Nilce Mitiko Matsuda; Paul J Pearson; Hartzell V Schaff; Carlos E Piccinato; Alfredo J Rodrigues; Paulo Roberto Barbosa Evora
Journal:  J Biomed Sci       Date:  2009-05-05       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.